Zhongnan Hospital clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.

1. Notable

   CAIX-PET · CAIX-targeted PET/CT in Solid Tumors

   Recruitment opened

   Zhongnan Hospital·Not applicable· NCT07833085· Registry history of NCT07833085 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

2. Notable

   Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab…Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

   Recruitment opened

   Also in this update: Interventions modified; Trial arms changed: 2 → 1

   Zhongnan Hospital·Phase 2· NCT07291401· Registry history of NCT07291401 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.